Synthesis of both enantiomers of 1,2,3,4-tetrahydroisoquinoline derivative IPPAM-1 and enantio-dependency of its positive allosteric modulation of prostacyclin receptor

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2567-2570. doi: 10.1016/j.bmcl.2017.03.083. Epub 2017 Mar 29.

Abstract

We present a practical synthesis of both enantiomers of 1,2,3,4-tetrahydroisoquinoline derivative IPPAM-1 (1), which is a positive allosteric modulator (PAM) of prostacyclin receptor (IP) and a candidate for treatment of pulmonary arterial hypertension without the side effects caused by IP agonists. Assay of cAMP production by CHO-K1 cells stably expressing human IP clearly demonstrated that the IPPAM activity resides exclusively on the R-form of 1.

Keywords: Positive allosteric modulator; Prostacyclin; Prostacyclin receptor; Pulmonary arterial hypertension; Tetrazole derivative.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allosteric Regulation
  • Animals
  • Antihypertensive Agents / chemical synthesis
  • Antihypertensive Agents / chemistry*
  • Antihypertensive Agents / therapeutic use
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Cyclic AMP / metabolism
  • Humans
  • Hypertension, Pulmonary / drug therapy
  • Receptors, Epoprostenol / agonists
  • Receptors, Epoprostenol / genetics
  • Receptors, Epoprostenol / metabolism*
  • Stereoisomerism
  • Tetrahydroisoquinolines / chemical synthesis
  • Tetrahydroisoquinolines / chemistry*
  • Tetrahydroisoquinolines / therapeutic use

Substances

  • Antihypertensive Agents
  • Receptors, Epoprostenol
  • Tetrahydroisoquinolines
  • Cyclic AMP